PODD Conference

Clare Beddoes, PhD, Head of Drug Delivery, Cambridge Design Partnership

Ann Daugherty, PhD, Senior Manager, Genentech

Showing Events in 1 Track from 08:30am to 08:55am

Brain Delivery Keynote

8:30AM - 8:55AM

Brain Delivery Keynote - A Targeted Approach to Gene Therapy Delivery to the Brain

Alfred Sandrock, MD, PhD, CEO, Voyager Therapeutics

Showing Events in 1 Track from 08:55am to 09:45am

Morning Sessions

8:55AM - 9:25AM

The Payer Perspective on Drug Delivery, Digital Health and Lifecycle Management

Mark Simon, MBA, Consultant, Stifel

Michael S. Sherman, MD, MBA, MS, EVP, CMO, Point32Health

Gail Ryan, PharmD, Director of Pharmaceutical Transformation, Point32Health

9:25AM - 9:45AM

Drug Delivery Pipeline & Technologies, a Year in Review

Kurt Sedo, Vice President, PharmaCircle

Showing Events in 1 Track from 09:45am to 10:35am

PODD Networking Break & Partnering

9:45AM - 10:35AM

PODD Networking Break & Partnering

Showing Events in 2 Tracks from 10:35am to 10:55am

Breakout A

Increasing Speed to Market with Partner-Focused Large-Volume Wearable Drug Delivery Device Development

Aaron Swick, MSE, Senior Staff Engineer, Research & Development, Enable Injections

Daniel Waites, PE, Director of Research & Development, Enable Injections

Breakout B

Demonstrating High Volume Autoinjector Delivery of 10 mL in ~30 sec: Halozyme Clinical Study HALO-104-105

Michael LaBarre, PhD, Chief Technical Officer, Halozyme

Showing Events in 1 Track from 10:55am to 12:50pm

Morning Session Continued

10:55AM - 11:15AM

Integrating Sustainability in Device Innovation: A Holistic Approach

Rasmus Just, MSc, MBA, Vice President, Device Innovation, Novo Nordisk

11:15AM - 11:45AM

Working Towards Sustainability in the Manufacturing and Development of Delivery Technology & Devices

Moderated By:

Monica Adams, PhD, MBA, Global Head , Packaging, Device, and Design Solutions, GSK

Sherri Biondi, PhD, Senior Director and Head of Device Development, AstraZeneca

Mark DeStefano, Associate Director, Combination Devices and Devices R&D, Teva

Bernd Mahlmann, MBA, Associate Director, Account & Business Development, Ypsomed

11:45AM - 12:00PM

A Patient and Planet Centric Approach to Enabling Drug Delivery

Sergie Letser, Deputy CCO and SVP Business Development, Nanoform

12:00PM - 12:50PM

PODD Annual Soapbox Presentations, Hosted by Pfizer

Chelsea Thorn, PhD, Senior Scientist, BioTherapeutics Pharmaceutical Science R&D, Pfizer

Hosted By:

Showing Events in 1 Track from 12:50pm to 01:55pm

Luncheon & Partnering Meetings

12:50PM - 1:55PM

Luncheon & Partnering Meetings

Showing Events in 3 Tracks from 02:00pm to 04:15pm

Track 1 - Indication-Specific Drug Delivery

Delivery Challenges from the Oncology Pipeline

Ronak Salva, PharmD, PhD, MBA, Director, Strategic Ventures, Catalent Pharma Solutions

Darren Reid, PhD, Director, Process Development, Amgen

Theresa Scheuble, Head, Enterprise Design & Innovation, Johnson and Johnson

Shankar Swaminathan, PhD, Associate Director, Drug Product Development, Astellas Institute for Regenerative Medicine, Astellas Pharma

Innovative Gastro-Retentive Drug Delivery Technologies for Improving Therapeutic Outcomes of Challenging Compounds

Pavan Handa, MBA, Senior Vice President, Specialty Portfolio Management, Amneal Pharmaceuticals

Siva Vaka, PhD, Director, R&D Formulations, Amneal Pharmaceuticals

Precision Ophthalmic Delivery

Jaymin Shah, PhD, Senior Research Fellow & Head of Topical and Advanced Drug Delivery, Pfizer

Cindy Wu, PhD, Director in Drug Delivery, AbbVie

Saurabh Wadhwa, PhD, Associate Director, Biotherapeutics Drug Product Development, Johnson & Johnson

Alex McKeown, PhD, MBA, Senior Director, Ophthalmology Research, Apellis Pharmaceuticals

New Approaches in CNS/PNS Delivery

Sujit Basu, PhD, Head, Pharmaceutical Development, Ionis Pharmaceuticals

Gabriele Proetzel, PhD, Senior Director, External Neuroscience Innovation, Takeda Pharmaceuticals

Bin Wu, PhD, Founder, President & CSO, Phosphorex

Haiming Wu, MS, MBA, Head of New Device Technology Research & Innovation, Sanofi

Novel Nasal Products and Formulations

Samantha Sarett, PhD, Senior Director, Nanomedicines, Eli Lilly and Company

Benjamin Bleier, MD, Associate Professor & Claire and John Bertucci Chair in Otolaryngology, Harvard Medical School

Krishna Subramanian, PhD, VP, Head of Non-Clinical & Translational Science, Seelos Therapeutics

Track 2 - Cell and Gene Delivery and Novel Delivery Modalities

Achieving Targeted Delivery of Gene Editing Therapies

Sanyogitta Puri, PhD, Senior Director, RNA & Gene Therapies - Non-Viral Delivery, Novo Nordisk

Sean Bedingfield, PhD, R&D Advisor - Genetic Medicine, Eli Lilly and Company

Manmohan Singh, PhD, Senior Vice President, Head, Pharmaceutical Sciences and Delivery Technologies, Beam Therapeutics

Liping Zhou, PhD, Senior Director, Advanced Drug Delivery, AstraZeneca

Shawn Davis, PhD, Executive Director, Drug Delivery, Biopharmaceuticals Development, AstraZeneca

Integrated Offering for mRNA Therapeutics

Greg Jarvis, Business Development Manager, CDMO Services mRNA, Lipids & LNP, Millipore Sigma

Overcoming Challenges to RNA and Oligonucleotide Delivery Beyond the Liver

Ana Gomes dos Santos, PhD, Principal Scientist, Advanced Drug Delivery, AstraZeneca

Ashoka Madduri, PhD, MBA, Head of Scientific Strategy & Competitive Intelligence, mRNA Center of Excellence, Sanofi

Oscar Marcos Contreras, PharmD, PhD, Research Assistant Professor, University of Pennsylvania

Kanika Suri, PhD, Scientist, Drug Product Development, CMC, Takeda Pharmaceuticals

The Promise and Challenges of Ultrasound-Mediated Delivery

Vincent Ling, PhD, Senior Director, Center for External Innovation, Takeda Pharmaceuticals

Isabelle Aubert, PhD, Senior Scientist, Sunnybrook Research Institute

Arjun "JJ" Dessai, Chief Strategic Innovation Officer, INSIGHTEC

Jérôme Marzinski, MBA, CEO, OxSonics

Per Walday, PhD, CEO, Exact Therapeutics

Overcoming Barriers to Adoption of Transdermal Delivery

Ester Caffarel-Salvador, PhD, Associate Director, Strategic Innovation, Rare Diseases, Chiesi USA

Natalie Artzi, PhD, Principal Research Scientist, MIT

Tycho Speaker, PhD, Director, Drug Delivery & Biomaterials, AbbVie

Track 3 - Device Development and Enabling Next-Generation Delivery

Holistic Approaches to Device Design and Development

Amir Tabaian, Senior Combination Product Engineer, Pfizer

Josh Horvath, PhD, Senior Director, Device & Packaging Development, Genentech

Courtney Nicholas Sutton, Associate Director, Device Development, AstraZeneca

Stefanie Johns, PhD, Director, Regulatory Affairs, Kymanox

Jason Durkin, VP of Supply Chain, Windgap Medical

Partnering to Create and Evolve an On-Body Injector

Matt Huddleston, CTO, Enable Injections

Jennifer Samproni, CTO, Health Solutions at Flex

The Future of Digital Technology in the Connected Device Space

Michael Song, PhD, Director, Moderna

Stephen Gianelis, Senior Director, Digital Health Operations, Teva Pharmaceuticals

Kate Hudson-Farmer, PhD, MBA, Partner, Global Health and Life Sciences, PA Consulting

Radu Iancu, MD, PhD, Founder & CEO, KeborMed

Amin Sedighiamiri, PhD, Associate Director, Device Development, AstraZeneca

Alternative Approaches to High-Volume/High-Concentration Injectable Delivery

Milin Shah, RPh, PhD, Associate Director, Gilead Sciences

Scott Ariagno, Vice President, Engineering & Development Services, EdgeOne Medical

Deep Bhattacharya, PhD, Senior Scientist Formulation and Process Development- Biotherapeutics, Pfizer

Ramesh Kashi, PhD, Senior Scientific Director, Sterile Product Development, Bristol-Myers Squibb

Michael Roe, PE, Senior Director, Development & Industrialization, Kaléo

Micromachines, Biologic Approaches and New Tools Pushing the Boundaries in Oral Delivery

Stephen Buckley, PhD, Director and Head of Oral Delivery Technology, Novo Nordisk

Ludwig Aguilar, PhD, Senior R&D Engineer, Novo Nordisk

Thomas von Erlach, PhD, Chief Scientific Officer, Co-Founder and Director, Vivtex

Showing Events in 1 Track from 04:15pm to 04:20pm

PODD Conference Concludes

4:15PM - 4:20PM

PODD Conference Concludes

Showing Events in 1 Track from 08:00am to 08:30am

Day 2 Morning General Session

8:00AM - 8:20AM

Morning Coffee (4th Floor)

8:20AM - 8:30AM

Co-Chair’s Opening Remarks

Clare Beddoes, PhD, Head of Drug Delivery, Cambridge Design Partnership

Ann Daugherty, PhD, Senior Manager, Genentech

Showing Events in 1 Track from 08:30am to 08:55am

Brain Delivery Keynote

8:30AM - 8:55AM

Brain Delivery Keynote - A Targeted Approach to Gene Therapy Delivery to the Brain

Alfred Sandrock, MD, PhD, CEO, Voyager Therapeutics

Showing Events in 1 Track from 08:55am to 09:45am

Morning Sessions

8:55AM - 9:25AM

The Payer Perspective on Drug Delivery, Digital Health and Lifecycle Management

Mark Simon, MBA, Consultant, Stifel

Michael S. Sherman, MD, MBA, MS, EVP, CMO, Point32Health

Gail Ryan, PharmD, Director of Pharmaceutical Transformation, Point32Health

9:25AM - 9:45AM

Drug Delivery Pipeline & Technologies, a Year in Review

Kurt Sedo, Vice President, PharmaCircle

Showing Events in 1 Track from 09:45am to 10:35am

PODD Networking Break & Partnering

9:45AM - 10:35AM

PODD Networking Break & Partnering

Showing Events in 2 Tracks from 10:35am to 10:55am

Breakout A

Increasing Speed to Market with Partner-Focused Large-Volume Wearable Drug Delivery Device Development

Aaron Swick, MSE, Senior Staff Engineer, Research & Development, Enable Injections

Daniel Waites, PE, Director of Research & Development, Enable Injections

Breakout B

Demonstrating High Volume Autoinjector Delivery of 10 mL in ~30 sec: Halozyme Clinical Study HALO-104-105

Michael LaBarre, PhD, Chief Technical Officer, Halozyme

Showing Events in 1 Track from 10:55am to 12:50pm

Morning Session Continued

10:55AM - 11:15AM

Integrating Sustainability in Device Innovation: A Holistic Approach

Rasmus Just, MSc, MBA, Vice President, Device Innovation, Novo Nordisk

11:15AM - 11:45AM

Working Towards Sustainability in the Manufacturing and Development of Delivery Technology & Devices

Moderated By:

Monica Adams, PhD, MBA, Global Head , Packaging, Device, and Design Solutions, GSK

Sherri Biondi, PhD, Senior Director and Head of Device Development, AstraZeneca

Mark DeStefano, Associate Director, Combination Devices and Devices R&D, Teva

Bernd Mahlmann, MBA, Associate Director, Account & Business Development, Ypsomed

11:45AM - 12:00PM

A Patient and Planet Centric Approach to Enabling Drug Delivery

Sergie Letser, Deputy CCO and SVP Business Development, Nanoform

12:00PM - 12:50PM

PODD Annual Soapbox Presentations, Hosted by Pfizer

Chelsea Thorn, PhD, Senior Scientist, BioTherapeutics Pharmaceutical Science R&D, Pfizer

Hosted By:

Showing Events in 1 Track from 12:50pm to 01:55pm

Luncheon & Partnering Meetings

12:50PM - 1:55PM

Luncheon & Partnering Meetings

Showing Events in 3 Tracks from 02:00pm to 04:15pm

Track 1 - Indication-Specific Drug Delivery

Delivery Challenges from the Oncology Pipeline

Ronak Salva, PharmD, PhD, MBA, Director, Strategic Ventures, Catalent Pharma Solutions

Darren Reid, PhD, Director, Process Development, Amgen

Theresa Scheuble, Head, Enterprise Design & Innovation, Johnson and Johnson

Shankar Swaminathan, PhD, Associate Director, Drug Product Development, Astellas Institute for Regenerative Medicine, Astellas Pharma

Innovative Gastro-Retentive Drug Delivery Technologies for Improving Therapeutic Outcomes of Challenging Compounds

Pavan Handa, MBA, Senior Vice President, Specialty Portfolio Management, Amneal Pharmaceuticals

Siva Vaka, PhD, Director, R&D Formulations, Amneal Pharmaceuticals

Precision Ophthalmic Delivery

Jaymin Shah, PhD, Senior Research Fellow & Head of Topical and Advanced Drug Delivery, Pfizer

Cindy Wu, PhD, Director in Drug Delivery, AbbVie

Saurabh Wadhwa, PhD, Associate Director, Biotherapeutics Drug Product Development, Johnson & Johnson

Alex McKeown, PhD, MBA, Senior Director, Ophthalmology Research, Apellis Pharmaceuticals

New Approaches in CNS/PNS Delivery

Sujit Basu, PhD, Head, Pharmaceutical Development, Ionis Pharmaceuticals

Gabriele Proetzel, PhD, Senior Director, External Neuroscience Innovation, Takeda Pharmaceuticals

Bin Wu, PhD, Founder, President & CSO, Phosphorex

Haiming Wu, MS, MBA, Head of New Device Technology Research & Innovation, Sanofi

Novel Nasal Products and Formulations

Samantha Sarett, PhD, Senior Director, Nanomedicines, Eli Lilly and Company

Benjamin Bleier, MD, Associate Professor & Claire and John Bertucci Chair in Otolaryngology, Harvard Medical School

Krishna Subramanian, PhD, VP, Head of Non-Clinical & Translational Science, Seelos Therapeutics

Track 2 - Cell and Gene Delivery and Novel Delivery Modalities

Achieving Targeted Delivery of Gene Editing Therapies

Sanyogitta Puri, PhD, Senior Director, RNA & Gene Therapies - Non-Viral Delivery, Novo Nordisk

Sean Bedingfield, PhD, R&D Advisor - Genetic Medicine, Eli Lilly and Company

Manmohan Singh, PhD, Senior Vice President, Head, Pharmaceutical Sciences and Delivery Technologies, Beam Therapeutics

Liping Zhou, PhD, Senior Director, Advanced Drug Delivery, AstraZeneca

Shawn Davis, PhD, Executive Director, Drug Delivery, Biopharmaceuticals Development, AstraZeneca

Integrated Offering for mRNA Therapeutics

Greg Jarvis, Business Development Manager, CDMO Services mRNA, Lipids & LNP, Millipore Sigma

Overcoming Challenges to RNA and Oligonucleotide Delivery Beyond the Liver

Ana Gomes dos Santos, PhD, Principal Scientist, Advanced Drug Delivery, AstraZeneca

Ashoka Madduri, PhD, MBA, Head of Scientific Strategy & Competitive Intelligence, mRNA Center of Excellence, Sanofi

Oscar Marcos Contreras, PharmD, PhD, Research Assistant Professor, University of Pennsylvania

Kanika Suri, PhD, Scientist, Drug Product Development, CMC, Takeda Pharmaceuticals

The Promise and Challenges of Ultrasound-Mediated Delivery

Vincent Ling, PhD, Senior Director, Center for External Innovation, Takeda Pharmaceuticals

Isabelle Aubert, PhD, Senior Scientist, Sunnybrook Research Institute

Arjun "JJ" Dessai, Chief Strategic Innovation Officer, INSIGHTEC

Jérôme Marzinski, MBA, CEO, OxSonics

Per Walday, PhD, CEO, Exact Therapeutics

Overcoming Barriers to Adoption of Transdermal Delivery

Ester Caffarel-Salvador, PhD, Associate Director, Strategic Innovation, Rare Diseases, Chiesi USA

Natalie Artzi, PhD, Principal Research Scientist, MIT

Tycho Speaker, PhD, Director, Drug Delivery & Biomaterials, AbbVie

Track 3 - Device Development and Enabling Next-Generation Delivery

Holistic Approaches to Device Design and Development

Amir Tabaian, Senior Combination Product Engineer, Pfizer

Josh Horvath, PhD, Senior Director, Device & Packaging Development, Genentech

Courtney Nicholas Sutton, Associate Director, Device Development, AstraZeneca

Stefanie Johns, PhD, Director, Regulatory Affairs, Kymanox

Jason Durkin, VP of Supply Chain, Windgap Medical

Partnering to Create and Evolve an On-Body Injector

Matt Huddleston, CTO, Enable Injections

Jennifer Samproni, CTO, Health Solutions at Flex

The Future of Digital Technology in the Connected Device Space

Michael Song, PhD, Director, Moderna

Stephen Gianelis, Senior Director, Digital Health Operations, Teva Pharmaceuticals

Kate Hudson-Farmer, PhD, MBA, Partner, Global Health and Life Sciences, PA Consulting

Radu Iancu, MD, PhD, Founder & CEO, KeborMed

Amin Sedighiamiri, PhD, Associate Director, Device Development, AstraZeneca

Alternative Approaches to High-Volume/High-Concentration Injectable Delivery

Milin Shah, RPh, PhD, Associate Director, Gilead Sciences

Scott Ariagno, Vice President, Engineering & Development Services, EdgeOne Medical

Deep Bhattacharya, PhD, Senior Scientist Formulation and Process Development- Biotherapeutics, Pfizer

Ramesh Kashi, PhD, Senior Scientific Director, Sterile Product Development, Bristol-Myers Squibb

Michael Roe, PE, Senior Director, Development & Industrialization, Kaléo

Micromachines, Biologic Approaches and New Tools Pushing the Boundaries in Oral Delivery

Stephen Buckley, PhD, Director and Head of Oral Delivery Technology, Novo Nordisk